XML 75 R47.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Quarterly Information (Unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract] |
Schedule of Quarterly Financial Information | The tables below present summarized unaudited quarterly results of operations for the years ended December 31, 2019 and 2018.
|  | Quarter Ended |  |
|  | March 31, |  |  | June 30, |  |  | September 30, |  |  | December 31, |  |
|  | (In thousands except per share amounts) |  |
2019: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 760,617 |  |  | $ | 789,362 |  |  | $ | 777,251 |  |  | $ | 780,232 |  |
Income before income taxes |  | $ | 36,871 |  |  | $ | 59,805 |  |  | $ | 49,560 |  |  | $ | (10,248 | ) |
Net income attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 29,471 |  |  | $ | 48,140 |  |  | $ | 42,566 |  |  | $ | (11,254 | ) | (1)
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 0.34 |  |  | $ | 0.55 |  |  | $ | 0.49 |  |  | $ | (0.13 | ) | (1)
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 0.34 |  |  | $ | 0.55 |  |  | $ | 0.48 |  |  | $ | (0.13 | ) | (1)
2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 742,241 |  |  | $ | 765,738 |  |  | $ | 760,916 |  |  | $ | 743,547 |  |
Income (loss) before income taxes |  | $ | 48,088 |  |  | $ | 69,258 |  |  | $ | 55,036 |  |  | $ | (341,336 | ) |
Net income (loss) attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 50,819 |  | (2) | $ | 58,836 |  |  | $ | 46,232 |  |  | $ | (331,637 | ) | (3)
Basic earnings per share attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 0.58 |  | (2) | $ | 0.67 |  |  | $ | 0.53 |  |  | $ | (3.80 | ) | (3)
Diluted earnings per share attributable to Acadia Healthcare Company, Inc. stockholders |  | $ | 0.58 |  | (2) | $ | 0.67 |  |  | $ | 0.53 |  |  | $ | (3.80 | ) | (3)
(1) | Includes a loss on impairment of $54.4 million.
(2) | Includes tax benefits of $10.5 million pursuant to a change in the Company’s provisional amounts recorded at December 31, 2017 related to the enactment of the Tax Act.
(3) | Includes loss on impairment of $337.9 million and legal settlements expense of $22.1 million.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=118952077&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration